Imfinzi 120mg/2.4ml

Imfinzi 120mg/2.4ml About

Imfinzi 120mg Injection is an anticancer drug used to treat several cancers, including non-small cell lung cancer, biliary tract cancer, liver cancer, and endometrial cancer. It works by blocking the PD-L1 protein on cancer cells. This allows the immune system to recognize and attack these cells more effectively.

Imfinzi 120mg Injection is administered as an intravenous infusion, typically given in a hospital or a clinical setting. Make sure to attend all scheduled appointments and follow your doctors instructions. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help optimize the treatment's effectiveness.

Common side effects include fatigue, cough, nausea, and loss of appetite. Some patients may experience diarrhea, skin rash, or shortness of breath. If you experience severe or persistent side effects, contact your doctor immediately. Staying hydrated and reporting side effects early can help manage them effectively.

While on Imfinzi 120mg Injection, avoid activities that can increase your risk of infection, such as contact with sick individuals or large crowds. The drug can cause immune-related side effects, such as inflammation of the lungs, liver, or intestines, so report any unusual symptoms promptly.

Mechanism of Action and Benefits

Imfinzi (Durvalumab) acts as a PD-L1 inhibitor, helping the immune system recognize and destroy cancer cells by preventing them from evading immune detection. For patients with certain types of lung cancer, Imfinzi can provide meaningful progression-free and overall survival benefits, especially after standard chemoradiotherapy has been completed.


Administration and Dosage Guidance

Imfinzi is administered as an intravenous infusion by qualified healthcare providers, generally every 2, 3, or 4 weeks, based on your doctor's instructions. Each vial contains 120mg Durvalumab in 2.4ml (50mg/ml). Administration must occur in a clinical setting to monitor for possible adverse reactions and ensure patient safety.


Storage, Packaging, and Handling

Imfinzi is supplied in single-use glass vials, each containing one dose. The solution should be stored in a refrigerator at 2C to 8C and not frozen. Each package contains one vial, and the product should only be used if the solution appears clear to slightly opalescent and colorless to slightly yellow. Check the expiry date before use.